The COPD Knowledge Centre contains a wide variety of resources to help you and your patients manage their condition including a selection of videos containing information about COPD from healthcare providers and those who are suffering from the disease; various patient materials; infographics available to view and download; a large selection of recent publication summaries; a number of COPD websites and guidelines we recommend you look at, and an upcoming conference and events section.
Visit the IPCRG page to download the desktop helper which provides an algorithm for the identification of patients that could benefit from inhaled corticosteroid treatment.
Recent questions answered by Dr Kai Beeh and Professor Pierre-Régis Burgel can now be found in the FAQ section. Topics that will be addressed include the evolving evidence from the FLAME study, how this may affect treatment decisions in clinical practice, the GOLD 2017 recommendations for COPD management, and whether your patients should receive ICS or be withdrawn from treatment.
A wide range of videos are available which outline COPD and the treatments available, including expert opinion on FLAME.
Read our FAQ section which contains answers to some important questions given by Dr Beeh, Professor Wedicha and Professor Burgel.
Explore the patient materials section, which has been designed to help your patients and their families better understand their disease.
Download a number of informative infographics which help to highlight the symptoms and challenges of COPD.
Read various publication summaries outlining a number of key clinical trials and the disease factors.
Have a look at some key upcoming events that are taking place within the respiratory field.
A number of useful links from various national and international societies and organisations have been collated here.
Guidelines are essential for the effective diagnosis, treatment and management of patients of all diseases, including those with COPD.
The IPCRG Desktop Helper provides an algorithm for the identification of COPD patients who may benefit from inhaled corticosteroids.